Evaluation of Mobile Applications for Patients with Diabetes Mellitus: A Scoping Review
There has been increasing interest in mobile healthcare for diabetes management. However, there remains limited evidence regarding the effectiveness of these mobile applications (apps). This scoping review aimed to evaluate the clinical effectiveness of mobile diabetes management apps. We used the f...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2024-01-01
|
| Series: | Healthcare |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2227-9032/12/3/368 |
| _version_ | 1797318770557976576 |
|---|---|
| author | Jung Lim Lee Youngji Kim |
| author_facet | Jung Lim Lee Youngji Kim |
| author_sort | Jung Lim Lee |
| collection | DOAJ |
| description | There has been increasing interest in mobile healthcare for diabetes management. However, there remains limited evidence regarding the effectiveness of these mobile applications (apps). This scoping review aimed to evaluate the clinical effectiveness of mobile diabetes management apps. We used the following search terms: “mobile app”, “mobile application”, and “diabetes”. We included only articles written in English and published between January 2016 and August 2021. We identified two, six, and four articles focused on type 1 diabetes, type 2 diabetes, and both diabetes types, respectively. Five, four, and three of these studies reported on the apps’ functionality, usability, and both, respectively. Our findings indicated that diabetes mobile apps allowed for convenient user experience and improved blood sugar levels in patients with diabetes. Considering these findings, usability must be comprehensively evaluated by using definitions such as the ISO9241-11 usability definition or the mobile application rating scale (MARS) when developing diabetes-related apps. For the feasibility of diabetes mobile apps, we recommend that HbA1C and self-management be included as evaluation variables. Given the increasing importance of continuous management for patients with diabetes, interventions using mobile apps are bound to become effective tools for patient-led self-management. |
| first_indexed | 2024-03-08T03:57:12Z |
| format | Article |
| id | doaj.art-eefbca4fa7fe4269ba05cf56b41bbc73 |
| institution | Directory Open Access Journal |
| issn | 2227-9032 |
| language | English |
| last_indexed | 2024-03-08T03:57:12Z |
| publishDate | 2024-01-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Healthcare |
| spelling | doaj.art-eefbca4fa7fe4269ba05cf56b41bbc732024-02-09T15:12:46ZengMDPI AGHealthcare2227-90322024-01-0112336810.3390/healthcare12030368Evaluation of Mobile Applications for Patients with Diabetes Mellitus: A Scoping ReviewJung Lim Lee0Youngji Kim1Department of Nursing, Daejeon University, Daejeon 34520, Republic of KoreaDepartment of Nursing, College of Nursing and Health, Kongju National University, Gongju 32588, Republic of KoreaThere has been increasing interest in mobile healthcare for diabetes management. However, there remains limited evidence regarding the effectiveness of these mobile applications (apps). This scoping review aimed to evaluate the clinical effectiveness of mobile diabetes management apps. We used the following search terms: “mobile app”, “mobile application”, and “diabetes”. We included only articles written in English and published between January 2016 and August 2021. We identified two, six, and four articles focused on type 1 diabetes, type 2 diabetes, and both diabetes types, respectively. Five, four, and three of these studies reported on the apps’ functionality, usability, and both, respectively. Our findings indicated that diabetes mobile apps allowed for convenient user experience and improved blood sugar levels in patients with diabetes. Considering these findings, usability must be comprehensively evaluated by using definitions such as the ISO9241-11 usability definition or the mobile application rating scale (MARS) when developing diabetes-related apps. For the feasibility of diabetes mobile apps, we recommend that HbA1C and self-management be included as evaluation variables. Given the increasing importance of continuous management for patients with diabetes, interventions using mobile apps are bound to become effective tools for patient-led self-management.https://www.mdpi.com/2227-9032/12/3/368diabetesmobile applicationsreviewtelemedicine |
| spellingShingle | Jung Lim Lee Youngji Kim Evaluation of Mobile Applications for Patients with Diabetes Mellitus: A Scoping Review Healthcare diabetes mobile applications review telemedicine |
| title | Evaluation of Mobile Applications for Patients with Diabetes Mellitus: A Scoping Review |
| title_full | Evaluation of Mobile Applications for Patients with Diabetes Mellitus: A Scoping Review |
| title_fullStr | Evaluation of Mobile Applications for Patients with Diabetes Mellitus: A Scoping Review |
| title_full_unstemmed | Evaluation of Mobile Applications for Patients with Diabetes Mellitus: A Scoping Review |
| title_short | Evaluation of Mobile Applications for Patients with Diabetes Mellitus: A Scoping Review |
| title_sort | evaluation of mobile applications for patients with diabetes mellitus a scoping review |
| topic | diabetes mobile applications review telemedicine |
| url | https://www.mdpi.com/2227-9032/12/3/368 |
| work_keys_str_mv | AT junglimlee evaluationofmobileapplicationsforpatientswithdiabetesmellitusascopingreview AT youngjikim evaluationofmobileapplicationsforpatientswithdiabetesmellitusascopingreview |